CluenexGE HealthCare Technologies GEHC
GE HealthCare Technologies scores average on business quality (4.7 of 10). Here is why, in plain words, and what our sealed record shows.
Why it matters
- What GE HealthCare Technologies does
GE HealthCare Technologies sells medical imaging systems, ultrasound, and patient care solutions to hospitals and diagnostic clinics worldwide. The company is advancing precision care software and digital infrastructure to connect hospital equipment and improve clinical workflows.
- What it does best
GE HealthCare dominates the installed base of hospital imaging equipment, locking in long-term service contracts. Its gross margin sits at 39.5%, trailing peer Edwards Lifesciences at 77.8% due to heavy hardware exposure, but service stickiness shields cash flow.
- The main risk
Supply chain disruptions and hospital spending freezes can delay multi-million dollar imaging system installations. Shares recently fell 21%, highlighting vulnerability to capital equipment budget swings in major healthcare networks.
Quality, check by check
Scored against its own industry, from company filings.
Operating margin stands at 12.9% and free cash flow margin is roughly 7.4%. Profitability is stable but constrained by hardware manufacturing costs, meaning margins scale slowly with volume.
The massive installed base of hospital hardware creates high switching costs, locking in enterprise buyers. Its operating margin sits in the 38th sector percentile, reflecting capital-heavy equipment competition.
Revenue grew 4.8% to $21.3B, sitting in the bottom quartile of its sector at the 28th percentile for growth. This top-line expansion is slowing compared to historical periods.
Total debt of $10.0B is offset by $4.5B in cash, producing net debt of $5.6B. Free cash flow of $1.58B covers interest expenses easily with coverage at 6.4x. The balance sheet is holding steady.
Insiders
Executives and directors, from SEC Form 4 filings we read ourselves. Open market trades only; grants, option exercises and pre-planned sales left out.
No open market buys or unplanned sales by executives or directors.
Our sealed record on GEHC
Verdicts appear here 30 days after we publish them; members see today's. Each one is in the nightly ledger, fingerprinted the night it was made.
The first sealed verdicts appear here on Oct 11, 2026.
Questions
GE HealthCare Technologies scores average on the Cluenex quality check (4.7 of 10), measured against its own industry. Profitability is weak, moat fair, growth slow and financial health fair.
In the last 90 days of SEC Form 4 filings: No open market buys or unplanned sales by executives or directors.
Oct 28, 2026.
See GEHC today
- Today's verdict on GEHC, and why
- Fair value with cautious, base and optimistic cases
- The exact price that would change the verdict
- Which stocks each signal names, the night it fires
Cite this page: Cluenex, “GE HealthCare Technologies (GEHC)”, https://cluenex.com/stocks/gehc/, data as of Oct 10, 2026.